VIEWPOINTS Erika Ross, Director of Clinical & Applied Research at Abbott Shares Insights on FDA Breakthrough Device Designation to Explore its DBS System to Treat Treatment-Resistant DepressionBySenior EditorOctober 5, 20220Comments
VIEWPOINTS Yoshio Okubo, Senior Director, Head of Pandemic Global Product Team for Takeda Shares Insights on the Approval of its Covid-19 VaccineBySenior EditorOctober 4, 20220Comments
EXCLUSIVE Nagesh Mahanthappa, Interim CEO of Scholar Rock Shares Insights on Treatment Options for Spinal Muscular AtrophyBySenior EditorOctober 3, 20220Comments
INSIGHTS+ PharmaShots’ Key Highlights of Third Quarter 2022BySenior EditorSeptember 29, 20220Comments
INSIGHTS+ Disease of the Month: Duchenne Muscular Dystrophy (DMD)BySenior EditorSeptember 29, 20220Comments
INSIGHTS+ Insights+: EMA Marketing Authorization of New Drugs in August 2022BySenior EditorSeptember 28, 20220Comments
VIEWPOINTS Jay Pathmanathan, Medical Director at Beacon Biosignals Shares Insights on EEG Neurobiomarkers for the Development of Precision Medicines in NeurologyBySenior EditorSeptember 27, 20220Comments
VIEWPOINTS Kindra Whitlatch, Product Applications Manager at ThermoFisher Scientific, Shares Insights on Drug Stability TestingBySenior EditorSeptember 26, 20220Comments
INSIGHTS+ Top Performing Drug of 2021 – Eylea (September Edition)BySenior EditorSeptember 22, 20220Comments
